Boyang Chang

691 total citations
26 papers, 458 citations indexed

About

Boyang Chang is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Boyang Chang has authored 26 papers receiving a total of 458 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 11 papers in Molecular Biology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Boyang Chang's work include Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Ferroptosis and cancer prognosis (4 papers). Boyang Chang is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Ferroptosis and cancer prognosis (4 papers). Boyang Chang collaborates with scholars based in China, United States and Canada. Boyang Chang's co-authors include Peihong Wu, Lujun Shen, Wang Li, Anxun Wang, Tao Huang, Qifeng Chen, Wenjun He, Liu Z, Xueqiang Ding and Kefeng Wang and has published in prestigious journals such as Nature Communications, Scientific Reports and European Journal of Pharmacology.

In The Last Decade

Boyang Chang

24 papers receiving 458 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Boyang Chang China	12	224	142	94	90	84	26	458
Mariachiara Santorsola Italy	13	218 1.0×	121 0.9×	92 1.0×	85 0.9×	39 0.5×	45	428
Keishi Nakamura Japan	14	227 1.0×	130 0.9×	168 1.8×	144 1.6×	105 1.3×	57	585
Shinsuke Kanekiyo Japan	15	250 1.1×	163 1.1×	113 1.2×	138 1.5×	93 1.1×	45	530
Tetsuya Urasaki Japan	12	205 0.9×	73 0.5×	107 1.1×	99 1.1×	45 0.5×	53	416
Jiansheng Li China	12	144 0.6×	138 1.0×	54 0.6×	77 0.9×	17 0.2×	29	396
Guo Long China	13	170 0.8×	213 1.5×	152 1.6×	60 0.7×	34 0.4×	26	492
Keigo Murakami Japan	11	245 1.1×	127 0.9×	132 1.4×	148 1.6×	26 0.3×	45	549
Manali Rupji United States	13	165 0.7×	186 1.3×	111 1.2×	65 0.7×	77 0.9×	45	479
Ying A. Wang United States	9	196 0.9×	166 1.2×	128 1.4×	41 0.5×	105 1.3×	11	417
Jing‐Yun Wen China	13	255 1.1×	172 1.2×	81 0.9×	67 0.7×	57 0.7×	36	594

Countries citing papers authored by Boyang Chang

Since Specialization

Citations

This map shows the geographic impact of Boyang Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boyang Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boyang Chang more than expected).

Fields of papers citing papers by Boyang Chang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Boyang Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boyang Chang. The network helps show where Boyang Chang may publish in the future.

Co-authorship network of co-authors of Boyang Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Boyang Chang. A scholar is included among the top collaborators of Boyang Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Boyang Chang. Boyang Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shao, Ruonan, Xiaoqing Li, Zhi Tian, et al.. (2025). Comprehensive investigation of cuproptosis-related genes in clinical features, biological characteristics, and immune microenvironment in B-cell Non-Hodgkin lymphoma. Journal of Translational Internal Medicine. 13(5). 456–471. 1 indexed citations

Chen, Shuanggang, Lujun Shen, Boyang Chang, et al.. (2025). Development and validation of the NTAA prognostic model for BCLC stage B hepatocellular carcinoma undergoing transarterial chemoembolization: a retrospective multicenter cohort study. International Journal of Surgery. 111(12). 9411–9420.

Gao, Ying, Denghui Wei, Li Zhong, et al.. (2025). Extracellular vesicles in cancer progression: mechanisms and significance. Science China Life Sciences.

Chen, Lu, et al.. (2025). EBF1-induced CSRP2 boosts the progression of B-cell acute lymphocytic leukemia by inhibiting ferroptosis. Cancer Letters. 614. 217556–217556. 5 indexed citations

Liu, Guanxiong, Quansheng He, Li He, et al.. (2024). Hepatic Arterial Infusion Chemotherapy Combined with Lenvatinib and PD-1 Inhibitors for Managing Arterioportal Shunt in Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: A Retrospective Cohort Study. Journal of Hepatocellular Carcinoma. Volume 11. 1415–1428. 5 indexed citations

Chang, Boyang, Zhengran Li, Chun Wu, et al.. (2024). Transarterial Chemoembolization (TACE) Combined with Lenvatinib versus TACE Alone in Intermediate-Stage Hepatocellular Carcinoma Patients Beyond Up-To-Seven Criteria: A Retrospective, Propensity Score-Matched Analysis. Academic Radiology. 31(11). 4456–4465. 5 indexed citations

Chang, Boyang, et al.. (2024). Clinical outcomes of modified transarterial chemoembolization vs. drug-eluting bead transarterial chemoembolization as initial treatment for single hepatocellular carcinoma: a propensity score matching analysis. Annals of Medicine. 56(1). 2423787–2423787. 1 indexed citations

Zhang, Baozhu, Boyang Chang, Lu Wang, & Yuzhong Xu. (2023). Three E2F target-related genes signature for predicting prognosis, immune features, and drug sensitivity in hepatocellular carcinoma. Frontiers in Molecular Biosciences. 10. 1266515–1266515. 1 indexed citations

Sun, Jin, Miao‐Zhen Qiu, Ting Mei, et al.. (2020). Dynamic monitoring of serum soluble programmed cell death ligand 1 as a response predictor to chemotherapy in metastatic or recurrent gastrointestinal cancer. Translational Cancer Research. 9(4). 2434–2448. 2 indexed citations

10.

Liu, Wenfen, Dong Wang, Hui Ouyang, et al.. (2019). Ultrasound Assessment of Muscle Injury Associated with Closed Limb Fracture. BioMed Research International. 2019. 1–9. 7 indexed citations

11.

Dong, Jun, Boyang Chang, Jinsheng Huang, et al.. (2019). An exploratory study of CT-guided percutaneous radiofrequency ablation for stage I thymoma. Cancer Imaging. 19(1). 80–80. 4 indexed citations

12.

Pan, Tao, Qiang Xie, Yanyang Zhang, et al.. (2019). Chiral ruthenium(II) complex Δ-[Ru(bpy)2(o-FMPIP)] (bpy = bipyridine, o-FMPIP = 2-(2′-trifluoromethyphenyl) imidazo[4,5-f][1,10]phenanthroline) as potential apoptosis inducer via DNA damage. European Journal of Pharmacology. 853. 49–55. 4 indexed citations

13.

Chang, Boyang, Wenjun He, Hui Ouyang, et al.. (2018). A Prognostic Nomogram Incorporating Depth of Tumor Invasion to Predict Long-term Overall Survival for Tongue Squamous Cell Carcinoma With R0 Resection. Journal of Cancer. 9(12). 2107–2115. 26 indexed citations

14.

Shen, Lujun, Qi Zeng, Pi Guo, et al.. (2018). Dynamically prognosticating patients with hepatocellular carcinoma through survival paths mapping based on time-series data. Nature Communications. 9(1). 2230–2230. 25 indexed citations

15.

Gao, Yuan, Li Su, Dazhi Xu, et al.. (2017). Prognostic value of programmed death-1, programmed death-ligand 1, programmed death-ligand 2 expression, and CD8(+) T cell density in primary tumors and metastatic lymph nodes from patients with stage T1-4N+M0 gastric adenocarcinoma. Chinese Journal of Cancer. 36(1). 61–61. 43 indexed citations

16.

Jiang, Liang, Boyang Chang, Mingcheng Huang, et al.. (2017). Oxymatrine prevents synovial inflammation and migration via blocking NF-κB activation in rheumatoid fibroblast-like synoviocytes. International Immunopharmacology. 55. 105–111. 45 indexed citations

17.

Chang, Boyang, Hang Yang, Jiao Yuan, et al.. (2016). SOD2 deregulation enhances migration, invasion and has poor prognosis in salivary adenoid cystic carcinoma. Scientific Reports. 6(1). 25918–25918. 41 indexed citations

18.

Wang, Kefeng, et al.. (2015). Once-weekly Subcutaneous Administration of Bortezomib in Patients with Multiple Myeloma. Asian Pacific Journal of Cancer Prevention. 16(5). 2093–2098. 12 indexed citations

19.

Zhao, Tingting, Xueqiang Ding, Boyang Chang, Xiaofeng Zhou, & Anxun Wang. (2015). MTUS1/ATIP3a down-regulation is associated with enhanced migration, invasion and poor prognosis in salivary adenoid cystic carcinoma. BMC Cancer. 15(1). 203–203. 30 indexed citations

20.

Chang, Boyang, Li Su, Qianting He, et al.. (2014). Deregulation of Bmi-1 is associated with enhanced migration, invasion and poor prognosis in salivary adenoid cystic carcinoma. Biochimica et Biophysica Acta (BBA) - General Subjects. 1840(12). 3285–3291. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact